Business Description
Eyebright Medical Technology (Beijing) Co Ltd
ISIN : CNE1000041J5
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.99 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 1.02 | |||||
Interest Coverage | 29.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 17.07 | |||||
Beneish M-Score | -1.59 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 43.4 | |||||
3-Year EBITDA Growth Rate | 36.6 | |||||
3-Year EPS without NRI Growth Rate | 39.9 | |||||
3-Year Book Growth Rate | 11.9 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 87.89 | |||||
9-Day RSI | 76.96 | |||||
14-Day RSI | 67.95 | |||||
6-1 Month Momentum % | -30.79 | |||||
12-1 Month Momentum % | -40.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.2 | |||||
Quick Ratio | 2.48 | |||||
Cash Ratio | 1.27 | |||||
Days Inventory | 187.63 | |||||
Days Sales Outstanding | 66.12 | |||||
Days Payable | 41.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.33 | |||||
Dividend Payout Ratio | 0.16 | |||||
Forward Dividend Yield % | 0.33 | |||||
5-Year Yield-on-Cost % | 0.33 | |||||
Shareholder Yield % | -0.39 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.47 | |||||
Operating Margin % | 33.95 | |||||
Net Margin % | 30.65 | |||||
FCF Margin % | -19.45 | |||||
ROE % | 15.87 | |||||
ROA % | 12.37 | |||||
ROIC % | 16.74 | |||||
ROC (Joel Greenblatt) % | 30.9 | |||||
ROCE % | 15.09 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 48.6 | |||||
PE Ratio without NRI | 47.03 | |||||
Price-to-Owner-Earnings | 134.25 | |||||
PEG Ratio | 1.07 | |||||
PS Ratio | 14.89 | |||||
PB Ratio | 7.18 | |||||
Price-to-Tangible-Book | 8.72 | |||||
Price-to-Operating-Cash-Flow | 66.71 | |||||
EV-to-EBIT | 43.42 | |||||
EV-to-EBITDA | 43.42 | |||||
EV-to-Revenue | 14.92 | |||||
EV-to-FCF | -75.13 | |||||
Price-to-Graham-Number | 4.27 | |||||
Price-to-Net-Current-Asset-Value | 133.77 | |||||
Earnings Yield (Greenblatt) % | 2.3 | |||||
FCF Yield % | -1.31 |